PM100117 and PM100118, Dos Nuevos Antitumorales de Pharma Mar , Muestran Actividad Potente contra Tres Lineas Celulares Tumorales Humanas ( Pulmón , Mama y Colón ) asi mismo Tambien Muestran Actividad AntiFungica Frente a Candida albicans ( Candidiasis ) . Según Revela un Estudio que Publica hoy la Revista Británica Nature.

The Journal of Antibiotics , (9 December 2015) .

PM100117 and PM100118, New Antitumor Macrolides produced by a marine Streptomyces caniferus GUA-06-05-006A

Marta Pérez, Carmen Schleissner, Rogelio Fernández, Pilar Rodríguez, Fernando Reyes, Paz Zuñiga, Fernando de la Calle and Carmen Cuevas .


Abstract :

Two new bioactive polyhydroxyl macrolide lactones PM100117 (1) and PM100118 (2) were isolated from the culture broth of the marine-derived Streptomyces caniferus GUA-06-05-006A.

Their structures were elucidated by a combination of spectroscopic methods, mainly one-dimensional and 2D NMR and HRESI-MS. They consist of 36-membered macrolides with a side chain containing three deoxy sugars and a 1,4-naphthoquinone chromophore.

Compounds 1 and 2 displayed potent cytotoxicity against three human tumor cell lines with GI50 values in the micromolar range, as well as slight antifungal activity against Candida albicans ATCC10231.

In addition, both compounds alter the plasma membrane of tumor cells, inducing loss of membrane integrity and subsequent cell permeabilization leading to a fast and dramatic necrotic cell death.